✨#HotPaper #mdpicancers☑️ "Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis" Find the full paper here⏩ https://lnkd.in/d7ZAVaKr
Cancers MDPI’s Post
More Relevant Posts
-
Chief of pathology and molecular pathology at Instituto Nacional De Cancerología / Scientific research at Fundación Universitaria de Ciencias de la Salud
We are glad to show our most recent article. PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis https://lnkd.in/eeR4bUxb
To view or add a comment, sign in
-
-
Cohort study aims to establish whether anterior vs posterior tumor extension may represent a prognostic factor in oral tongue and floor squamous cell carcinoma. https://ja.ma/3ODk2Q9
To view or add a comment, sign in
-
Gain valuable insights into how collaboration among different healthcare professionals can lead to early detection and better outcomes for patients with advanced cases of basal cell carcinoma (BCC) and advanced cutaneous squamous cell carcinoma (CSCC). Register here: https://okt.to/jbM5hq
To view or add a comment, sign in
-
-
Gain valuable insights into how collaboration among different healthcare professionals can lead to early detection and better outcomes for patients with advanced cases of basal cell carcinoma (BCC) and advanced cutaneous squamous cell carcinoma (CSCC). Register here: https://okt.to/RpId8e
To view or add a comment, sign in
-
-
Data on the use of rigosertib in patients with RDEB-associated squamous cell carcinoma was presented at the EADV Congress last week: https://lnkd.in/eEuUDJQF EB-associated squamous cell carcinoma is a leading cause of premature death in patients with RDEB, so while we search for a cure, we must also search for treatments to prevent and slow the progression of EB-associated SCC. We are pleased to support this promising work - you can read more about the trial in the Current Research section of our website. #CureEB #ResearchtheCure #EBResearch #Research #RDEB #EADV23
To view or add a comment, sign in
-
You see everything in primary care. This series covers common conditions in quick takes. More in depth courses are found for free on our website for clinicians. If you'd like to get involved or support us, get in touch.. #meded #freecourseswithcertificates #democratisingmedicaleducation
Our quick take, 3 fact series on YouTube, out tomorrow on Basal Cell Carcinoma https://lnkd.in/ezasJHBm
To view or add a comment, sign in
-
-
The neoadjuvant combination of camrelizumab, nab-paclitaxel & cisplatin demonstrated statistically significant enhancements in pCRs compared with solitary chemotherapy in resectable locally advanced esophageal squamous cell carcinoma. https://lnkd.in/ei3axH2q
To view or add a comment, sign in
-
-
Ophthopedia Update:Squamous cell carcinoma on the head of a primary pterygium: Eye, Published online: 23 April 2024; doi:10.1038/s41433-024-03095-0Squamous cell carcinoma on the head of a primary pterygium #Ophthalmology #Eye #Ophthotwitter
Squamous cell carcinoma on the head of a primary pterygium - Eye
nature.com
To view or add a comment, sign in
-
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
To view or add a comment, sign in
-
-
Clinical response of T3 squamous cell carcinoma of the tongue, treated with neoadjuvant pembrolizumab-carboplatin-paclitaxel. Significant reduction of the tumor size.
To view or add a comment, sign in
-